A severe case of rhabdomyolysis after Moderna mRNA anti‐COVID‐19 vaccine with a literature review

Abstract

The identification of rhabdomyolysis as a potential fatal adverse reaction to recent COVID-19 vaccines is essential. As the symptoms of rhabdomyolysis are not specific, the threshold to actively search for this complication should be low.

The mRNA-LNP vaccines – the good, the bad and the ugly?

“…The Countermeasures Injury Compensation Program(CICP) data show that out of a total of 13,406 CICP claims ever filed, 12,854 were COVID-19 countermeasure claims, out of which 9,682 allege injuries/deaths from COVID-19 vaccines ( 50 ). Peer-reviewed case reports, including but not limited to severe inflammatory/autoimmune events of bone marrow ( 51 – 55 ), liver ( 56 – 58 ), skin ( 59 – 64 ), cardiovascular- ( 65 – 77 ), musculoskeletal- ( 76 , 78 , 79 ), endocrine- ( 80 – 84 ), and nervous system ( 66 , 84 – 87 ), etc. that sometimes had been fatal, have been steadily increasing.…”